134 related articles for article (PubMed ID: 36731037)
21. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
[No Abstract] [Full Text] [Related]
23. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
Worrell HI; Sciallis AP; Skala SL
Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390
[TBL] [Abstract][Full Text] [Related]
24. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
25. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
26. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
Zhao L; Cheng YW; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
[TBL] [Abstract][Full Text] [Related]
27. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
Yildirim HT; Nergiz D; Sadullahoglu C; Akgunduz Z; Yildirim S; Dogan S; Sezer C
Indian J Pathol Microbiol; 2020; 63(3):412-417. PubMed ID: 32769330
[TBL] [Abstract][Full Text] [Related]
28. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features.
Joehlin-Price A; Van Ziffle J; Hills NK; Ladwig N; Rabban JT; Garg K
Am J Surg Pathol; 2021 Mar; 45(3):421-429. PubMed ID: 33021522
[TBL] [Abstract][Full Text] [Related]
29. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
Lawrenson K; Pakzamir E; Liu B; Lee JM; Delgado MK; Duncan K; Gayther SA; Liu S; Roman L; Mhawech-Fauceglia P
PLoS One; 2015; 10(7):e0130909. PubMed ID: 26132201
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
[TBL] [Abstract][Full Text] [Related]
32. The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma.
Monaghan H; MacWhinnie N; Williams AR
Histopathology; 2007 Feb; 50(3):348-57. PubMed ID: 17257130
[TBL] [Abstract][Full Text] [Related]
33. ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change.
Ondič O; Bednářová B; Ptáková N; Hájková V; Šteiner P; Šidlová H; Presl J; Bouda J; Alaghehbandan R; Michal M
Virchows Arch; 2020 Apr; 476(4):615-619. PubMed ID: 31938824
[TBL] [Abstract][Full Text] [Related]
34. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
35. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
[TBL] [Abstract][Full Text] [Related]
36. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
37. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
[TBL] [Abstract][Full Text] [Related]
38. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
Sun L; Zhao W; Zhao Z; Zhu Y
Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
